Timing is everything for cancer protein p53
Biologists find that restoring the gene for p53 can slow the spread of advanced lung tumors, but doesn’t help early-stage cancers.
A better way to target tumors
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
Teasing out malaria’s genetic secrets
Biological engineer’s new approach to studying gene control could lead to new drug targets.
Squeezing more production out of bacteria
MIT chemical engineers demonstrate a new way to dramatically boost bacteria’s manufacturing abilities.
Lunch with a Laureate: Robert Horvitz
Presented by the MIT Museum and the Cambridge Science Festival
Proteins linked to longevity also linked to Alzheimer’s
Sirtuins appear to control production of the devastating protein fragments that form plaques in the brains of Alzheimer’s patients.
Imaging fish on the fly
New MIT technology allows high-speed study of zebrafish larvae, often used to model human diseases.
A new use for gold
Engineers turn a drawback — the stickiness of gold nanoparticles — into an advantage.
Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.
Bacteria divide like clockwork
MIT researchers show how circadian rhythms in bacteria control their rate of reproduction.
Y chromosomes evolving rapidly
By comparing human and chimpanzee Y chromosome sequences, Whitehead Institute geneticists show the Y is undergoing swift change.
Silencing the brain with light
MIT neuroengineers find a new way to quickly and reversibly shut off neurons with multiple colors of light, which could lead to new treatments for epilepsy and chronic pain.